【レポートの概要（一部）】
1. Introduction to Cancer Immunotherapy
2. Classification of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.2 Non-Specific Cancer Immunotherapy
3. Cancer Immunotherapy by Vaccines
3.1 Introduction
3.2 Mechanism of Vaccines in Cancer Immunotherapy
3.2.1 Idiotype Cancer Vaccine Mechanism
3.2.2 Cellular Cancer Vaccines Mechanism
3.2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
3.2.4 Peptide Cancer Vaccine Mechanism
3.2.5 Tumor Host Interaction Cancer Vaccine Mechanism
4. Cancer Immunotherapy by Monoclonal Antibodies
4.1 Introduction
4.2 Mechanism of Monoclonal Antibodies in Cancer Immunotherapy
5. Cancer Immunotherapy by Adoptive Cell Transfer
5.1 Introduction
5.2 Mechanism of Adoptive Cell Transfer Cancer Immunotherapy
6. Cancer Immunotherapy by Immune Checkpoint Inhibitors
6.1 Introduction
6.2 Mechanism of Immune Checkpoint Inhibitors in Cancer Immunotherapy
7. Cancer Immunotherapy by Immunomodulators
7.1 Introduction
7.2 Mechanism of Immunomodulators in Cancer Immunotherapy
8. Cancer Immunotherapy by Cytokines
8.1 Introduction
8.2 Mechanism of Cytokines Cancer Immunotherapy
9. Cancer Immunotherapy by Interleukins
9.1 Introduction
9.2 Mechanism of Interleukinsin Cancer Immunotherapy
10. Cancer Immunotherapy by Interferon
10.1 Introduction
10.2 Mechanism of Interferon Cancer Immunotherapy
11. Cancer Immunotherapy by GM-CSF
11.1 Introduction
11.2 Mechanism of GM-CSF Cancer Immunotherapy
12. Cancer Immunotherapy Market Overview
12.1 Current Market Scenario
12.2 Cancer Immunotherapy Pipeline Overview
13. Global Cancer Immunotherapy Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges
14. Global Cancer Immunotherapy Market Future Prospects
15. Cancer Cell Therapies Clinical Pipeline by Company, Indication & Phase
15.1 Unknown
15.2 Research
15.3 Preclinical
15.4 Clinical
15.5 Phase-I
15.6 Phase-I/II
15.7 Phase-II
15.8 Phase-III
15.9 Preregistration
16. Marketed Cancer Cell Therapies Drugs Clinical Insight
16.1 Sipuleucel-T (Provenge®)
16.2 T-Lymphocyte Cell Therapy(Immuncell-LC®)
17. Cancer Cytokines Clinical Pipeline by Company, Indication & Phase
17.1 Unknown
17.2 Research
17.3 Preclinical
17.4 Clinical
17.5 Phase-I
17.6 Phase-I/II
17.7 Phase-II
17.8 Phase-III
18. Marketed Cancer Cytokines Drugs Clinical Insight
18.1 Aldesleukin (Proleukin®)
18.2 Denileukin Diftitox (ONTAK®)
18.3 Interferon Alpha (Multiferon®)
18.4 Interferon Alpha-2a (Roferon-A®)
18.5 Interferon Alpha-2a (Veldona®)
18.6 Interferon Alpha-2a Biosimilar(Inferon™/Inmutag™)
18.7 Interferon Alpha-2b(Intron® A)
18.8 Interferon Alpha-2b Biosimilar(Bioferon™)
18.9 Interferon Alpha-2b Biosimilar (Intalfa®)
18.10 Interferon Alpha-2b Biosimilar
18.11 Interferon-Alpha-n3 (Alferon N®)
18.12 Interferon-Beta-1b (Feron®)
18.13 Interferon-Gamma (Ogamma®)
18.14 Interleukin-2 Biosimilar (Ilcass)
18.15 Teceleukin (Imunace™)
19. Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase
19.1 Unknown
19.2 Research
19.3 Preclinical
19.4 Clinical
19.5 Phase-I
19.6 Phase-I/II
19.7 Phase-II
19.8 Phase-II/III
19.9 Phase-III
19.10 Preregistration
19.11 Registered
20. Marketed Cancer Immunomodulators Clinical Insight
21. Cancer Vaccine Clinical Pipeline By Company, Indication & Phase
21.1 Research
21.2 Preclinical
21.3 Clinical
21.4 Phase-I
21.5 Phase-I/II
21.6 Phase-II
21.7 Phase-II/III
21.8 Phase-III
21.9 Preregistration
21.10 Registered
22. Marketed Cancer Vaccines Clinical Insight
22.1 Bladder Cancer Vaccine (PACIS®)
22.2 Bladder Cancer Vaccine
22.3 BV NSCLC 001
22.4 Dendritic Cell Vaccine (CreaVax-HCC®, CreaVax-PC® & CreaVax-RCC®)
22.5 Human Papillomavirus Vaccine Quadrivalent (Gardasil®/Silgard®)
22.6 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
22.7 Melanoma Vaccine (MVax®)
22.8 Melanoma Vaccine (Melacine®)
22.9 Racotumomab (Vaxira®)
22.10 Sipuleucel-T (Provenge®)
22.11 Tertomotide (LucaVax)
22.12 Vitespen (Oncophage®)
23. Cancer Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase
23.1 Unknown
23.2 Research
23.3 Preclinical
23.4 Clinical
23.5 Phase-I
23.6 Phase-I/II
23.7 Phase-II
23.8 Phase-II/III
23.9 Phase-III
23.10 Preregistration
23.11 Registered
24. Marketed Cancer Monoclonal Antibodies Drugs Clinical Insight
25. Competitive Landscape
25.1 Abbvie
25.2 Advaxis
25.3 Altor BioScience
25.4 Amgen
25.5 Biogen Idec
25.6 Biogenomics
25.7 Celldex Therapeutics
25.8 Dendreon Corporation
25.9 Eli Lilly
25.10 Expression Genetics
25.11 Galena Biopharma
25.12 Genmab
25.13 Gilead Sciences
25.14 GlaxoSmithKline
25.15 ImmunoCellular Therapeutics
25.16 ImmunoGen
25.17 Inovio Pharmaceuticals
25.18 IRX Therapeutics
25.19 Merck
25.20 NeoStem Oncology
25.21 NewLink Genetics
25.22 Northwest Biotherapeutics
25.23 Novartis
25.24 Peregrine Pharmaceuticals
25.25 Pfizer
25.26 Philogen
25.27 Regulon
25.28 Roche
25.29 Seattle Genetics
25.30 ZymoGenetics
【レポート販売概要】
■ タイトル：癌免疫療法の世界市場動向■ 英文：Global Cancer Immunotherapy Market Outlook 2020
■ 発行日：2015年6月
■ 調査会社：KuicK Research
■ 商品コード：KUIK506192
■ 調査対象地域：グローバル
- Fungemia：グローバル臨床試験レビューH2, 2013Fungemia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2013" provides data on the Fungemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fungemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ENT（耳鼻咽喉科）疾患治療の世界市場ABSTRACTAbout ENT Disorder Treatment ENT also known as otolaryngology, is an area of medicine that deals with disorders of ear, nose, and throat. Dysfunction of these body parts can affect quality of life and in certain cases may even lead to medical emergency. The market encompasses drugs that are used for the treatment of the ENT disorder. It mainly considers the various drug class used for the …
- 油脂の世界市場予測（～2021年）：パーム油、大豆油、菜種油、ひまわり油、オリーブ油The fats & oils market is projected to grow at a CAGR of 4.4%, in terms of value, from 2016 to reach a projected value of USD 247.78 Billion by 2021. The market is driven by the demand from Asia-Pacific countries, particularly India, China, Malaysia, and Indonesia. Demand from the respective food sectors of these countries, which are supported by rise in living standards and population growth are …
- 二輪車用無段変速機の世界市場2016-2020About Continuously Variable Transmission Market for Two-Wheelers CVT in two-wheelers is generally used in the scooter segment. Almost all scooters are now equipped with CVT whereas most of the motorbikes are equipped with manual transmission technology. Unlike manual transmission, CVT does not have gear shift but instead has infinite gear ratios, whose transition takes place almost seamlessly with …
- 産業用ターボチャージャーの世界市場2016-2020About the Industrial Turbocharger Market Efficiency and power of an engine or motor dictate the overall functioning of the machine. The engine output is determined by the amount of air and fuel entering the internal combustion engine under high pressure. A turbocharger is an example of a forced induction system as it supplies high pressurized exhaust gas to the engine, making more air available fo …
- Madhya Pradesh Power Generating Company Limited：発電所及び企業SWTO分析2015Madhya Pradesh Power Generating Company Limited - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plan …
- 世界の自動車用ピストン市場：用途別、地域別Global Automotive Piston Market: About this market Technavio’s automotive piston market analysis considers sales from both passenger vehicles and commercial vehicle applications. Our study also finds the sales of the automotive piston in APAC, Europe, MEA, North America, and South America. In 2019, the passenger vehicle segment had a significant market share, and this trend is expected to continue …
- フマル酸の世界市場2015-2019About fumaric acid Fumaric acid is a white crystalline trans-butenedioic acid widely available in nature. It is more economical than other food acids (on a cost per unit weight basis); hence, it has potential to replace other acidulants such as citric and malic acids. In addition, its anti-microbial properties coupled with non-hygroscopic character makes an ideal choice for dry mix products and gi …
- 世界の鉄鋼（Steel）市場予測：建設、自動車、機械、家電、エネルギー、金属製品、造船分野用途Visiongain predicts the world steel market will reach $1.15 trillion in 2014. The construction, automobile, and white goods industries will attract a high demand for steel over the next decade. Vast opportunities exist where the unique properties of steel are critical. This could result in a much larger market penetration. Global steel demand over the next decade will largely depend on the emergin …
- 追跡ソリューションの世界市場予測（～2021年）：バーコードスキャナ、プラントマネジャー、ラベリング、モニタリング＆検証The global healthcare track and trace solutions market is estimated to reach USD 2.81 Billion by 2021, at a CAGR of 17.3% during the forecast period. The increasing focus of manufacturers on brand protection and growth in number of packaging-related product recalls are driving market growth. The rising number of manufacturing facilities in developing regions presents significant growth opportuniti …
- 世界の立方晶窒化硼素市場2015The Global Cubic Boron Nitride Industry Report 2015 is a professional and in-depth study on the current state of the Cubic Boron Nitride industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cubic Boron Nitride market analyses is provided for the international markets including development trends, compe …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- Centrica plc：石油・ガスバリューチェーン分析レポート2013Centrica plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Centrica plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Centrica plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s busin …
- 世界の3D IC市場動向（2012-2016）TechNavio's analysts forecast the Global 3D IC market to grow at a CAGR of 19.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the huge demand for memory-enhanced applications. The Global 3D IC market has also been witnessing the increase of multi-chip packaging. However, the thermal conductivity issues could pose a challenge to the growth of this m …
- Competitive Intelligence: World Automated Microbiology Market Key Players–Strategic Assessments of Major Suppliers and Emerging Market EntrantsThis new 98-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The assessments include sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. The companies analyzed in the report include Abbott, Affymetrix, Agilen …
